Search results for: 'Preferred Destination for Early Phase Clinical Trials'

19 Jan 2018  |  North America  |  Market Research

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

The Next Generation of Cancer Therapies

Infographics

×

Key Issues Addressed

Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...

The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

France is far behind Netherlands, which has the highest penetration rate of medical imaging contracts under non-conventional business models such as managed equipment services (MES) and multi-vendor services (MVS), and behind the United Kingdom, which has the largest number of such contracts. The French Ministry of Health’s substantial cost-cutting...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

03 Jan 2017  |  North America  |  Market Research

North American and European Architectural Coatings Market, Forecast to 2023

Changes in Customer Preferences, Regulatory Rules, and Product Advancements will Boost Market Growth

Infographics

×

Scope of the Study This research study includes the following segments: Scope: Architectural coatings. Segmented by chemistry (acrylics, alkyds, polyurethanes, others) and segmented by technology (waterborne, solvent-borne) Geographic scope: North America and Europe End-user scope: Architectural coating manufacturers, coating manufacturers, profe...

17 Dec 2015  |  North America  |  Market Research

Analysis of the Global Polyols Market

Growing Customer Preference for Superior Quality and Durable Polyurethane Products to Boost Revenue

Infographics

×

The key product segments covered in this research service are polyether and polyester polyols. Key trends in the natural oil polyols market have also been included. Regional-level splits of polyol consumption in flexible foam, rigid foam, and coatings, adhesives, sealants, and elastomers applications have also been provided for each segment. The se...

This research analyzes the global trends in the portable CMM market. It has steadily grown, with demand predominantly coming from the automotive, machine shop, and aerospace industries. The disruption caused by the onset of COVID-19 resulted in contracted demand across these industries, and the economic uncertainty resulted in customers being cauti...

09 Apr 2024  |  North America  |  Market Research

US and European Home Care Digitalization Growth Opportunities Forecast to 2028

Technology will Support Consumer Preferences for Receiving Care in the Comfort of Home

Infographics

×

Home has become an attractive care delivery site because of the convenience, affordability, and patient-centric care environment it offers. The home care digitalization industry represents technologies that home care agencies use to improve/enhance services for the end user (B2B2C). The industry picked up pace during the COVID-19 pandemic and has s...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...